Marc de Perrot, MD

Senior Scientist, Toronto General Hospital Research Institute (TGHRI)

Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre

Dr. de Perrot’s research focuses on innovative approaches to integrate immunotherapy with a short course of radiation and surgery for the treatment of mesothelioma. His work also focuses on the role of the immune system in the development of pulmonary hypertension, particularly in the context of pulmonary emboli. The surgical treatment of CTEPH with pulmonary thromboendarterectomy (PTE) performed at UHN provides unique opportunities to analyze this condition in the his laboratory. His laboratory has developed multiple experimental models to study the development and treatment of mesothelioma.